The correlation study between post-surgery oxygen partial pressure level and prognosis of patients with sepsis during hospitalization

术后氧分压水平与脓毒症住院患者预后的相关性研究

阅读:2

Abstract

Sepsis remains a leading cause of mortality and healthcare burden, necessitating improved diagnostic and therapeutic strategies. Observational studies suggest that hyperoxemia may improve postoperative sepsis outcomes, but evidence remains limited. This study aims to explore the optimal range of oxygen partial pressure (PaO2) in postsurgical sepsis patients and its impact on prognosis. Clinical data of adult sepsis patients were extracted from the medical information mart for intensive care-IV database. Patients were categorized into control (PaO2 ≤ 100 mm Hg) and hyperoxemia (PaO2 > 100 mm Hg) groups. Primary outcome was 90-day mortality, while secondary outcomes included 1-year mortality, intensive care unit (ICU)/hospital length of stay, and invasive ventilation duration. Restricted cubic spline analysis stratified postsurgical PaO2 into normal (≤128.7 mm Hg), mild hyperoxemia (128.7-162.1 mm Hg), and severe hyperoxemia (≥162.1 mm Hg). Kaplan-Meier survival analysis and multivariate regression were conducted. Among 1220 patients, hyperoxemia patients were younger, had lower disease severity, and received more aggressive treatment. They had lower rates of acute respiratory failure and acute kidney injury. After cubic spline-based classification, mild hyperoxemia was associated with lower 90-day mortality (OR: 0.54, 95% CI: 0.34-0.86, P = .010), while severe hyperoxemia showed no significant effect (OR: 0.60, 95% CI: 0.30-1.20, P = .147). Kaplan-Meier curves demonstrated significantly improved long-term survival for mild hyperoxemia patients. Mild hyperoxemia in postsurgical sepsis patients is associated with reduced 90-day mortality, suggesting a potential optimal oxygenation range for better outcomes.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。